Procter & Gamble: The Outlook Is Worrying (Rating Downgrade)

Procter & Gamble (PG) reported Q4 net sales of $20.9 billion (+2% YoY) and core EPS of $1.48 (+6% YoY), both exceeding estimates, with EPS growth driven by operating margin expansion despite modest top-line performance. However, the company's FY2026 guidance projects organic sales and core EPS growth to decelerate significantly to just 2%, suggesting a plateau in efficiency gains. This outlook, combined with reduced capital returns and a forward P/E ratio still above the sector median, renders the valuation unattractive and technicals bearish, prompting a 'Sell' rating.

Analysis

Procter & Gamble's Q4 earnings present a narrative of fleeting profitability gains overshadowed by a weak forward outlook. The company reported a 2% YoY increase in net sales to $20.9 billion, a modest figure that nonetheless beat LSEG estimates. This growth was entirely driven by price and mix, as organic volumes were flat, indicating business resilience in a tough macro environment but a fundamental lack of volume growth. The primary bright spot was a 6% YoY increase in core EPS to $1.48, fueled by a 150 basis point expansion in core operating margin from significant SG&A efficiencies. However, this was not broad-based strength, as core gross margin contracted 70 basis points, partly due to a 40 basis point headwind from tariffs. The optimism from this operational leverage is immediately tempered by the FY2026 guidance, which projects both organic sales and core EPS growth to decelerate to a mere 2%. This forecast suggests the efficiency gains have plateaued and implies margin stagnation. Furthermore, the company plans to reduce share repurchases from $6.5 billion to $5.0 billion, lowering total capital returns. The stock's forward P/E of 22.13, while below its historical average, remains significantly above the sector median of 18.73, an unattractive premium given the anemic growth outlook and bearish technical signals.

Key Decisions for Investors

• Investors should recognize that the Q4 EPS beat was driven by one-off efficiency gains, as FY2026 guidance for 2% EPS growth suggests profitability improvements have likely run their course.
• The valuation appears unattractive, with the forward P/E of 22.13 trading at a significant premium to the sector median of 18.73, which seems unjustified given the forecast for multi-year low earnings growth.
• Consider the impact of reduced capital returns, as planned share repurchases are set to decline by $1.5 billion in FY2026, which, combined with bearish technical indicators, may limit near-term upside potential.